HI
OGEN icon

Harbour Investments’s Oragenics OGEN Stock Holding History

Harbour Investments’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20 Hold
34
– – ﹤0.01% 4721
2026
Q1 		$19 Hold
34
– – ﹤0.01% 4625
2025
Q4 		$27 Hold
34
– – ﹤0.01% 3817
2025
Q3 		$45 Hold
34
– – ﹤0.01% 3681
2025
Q2 		$130 Buy
+34
New +$172 ﹤0.01% 3503

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
ASCM
Adkins Seale Capital Management Shreveport, Louisiana $112M AUM

Harbour Investments's OGEN Position: Q2 2026 in Review

Harbour Investments held its Oragenics (OGEN) position steady in Q2 2026 at 34 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #4721.

Harbour Investments first reported a position in OGEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $130 in Q2 2025. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • Harbour Investments held 34 shares of Oragenics worth $20 as of Q2 2026.
  • Harbour Investments left its Oragenics share count unchanged in Q2 2026.
  • Oragenics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4721 holding.
  • Harbour Investments first reported a position in Oragenics in Q2 2025 and has held it in 5 quarters since.
  • Harbour Investments's Oragenics position peaked at $130 in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.